Brian A. Kirk

发表

Discovery and investigation of a novel class of thiophene-derived antagonists of the human glucagon receptor.

V. Ding, S. Qureshi, D. Szalkowski, 2005, Bioorganic & medicinal chemistry letters.

Synthesis and activity of novel HIV protease inhibitors with improved potency against multiple PI-resistant viral strains.

Jiunn H. Lin, L. Kuo, W. Schleif, 2002, Bioorganic & medicinal chemistry letters.

Glycosylation with 2′-thio-S-acetyl participation

S. Knapp, Brian A. Kirk, 2003 .

Competitive intramolecular TiC versus AlC alkene insertions: Examining the role of Lewis acid cocatalysts in Ziegler-Natta alkene insertion and chain transfer reactions

N. Barta, J. Stille, Brian A. Kirk, 1995 .

Direct observation (NMR) of the efficacy of glucagon receptor antagonists in murine liver expressing the human glucagon receptor.

V. Ding, Bei B. Zhang, G. Kaczorowski, 2006, Bioorganic & Medicinal Chemistry.

HIV-1 protease inhibitors with picomolar potency against PI-resistant HIV-1 by modification of the P1' substituent.

Jiunn H. Lin, L. Kuo, W. Schleif, 2003, Bioorganic & medicinal chemistry letters.

.alpha.- and .beta.-Deuterium Isotope Effects in the MgX2 and Methylaluminoxane Promoted Intramolecular Olefin Insertion of Cp2TiClR Complexes. Insight into Cocatalyst Dependence and Chain End Control in Ziegler-Natta Polymerization

N. Barta, J. Stille, Brian A. Kirk, 1994 .

NAG-thiazoline, An N-Acetyl-β-hexosaminidase Inhibitor That Implicates Acetamido Participation

S. Withers, D. Vocadlo, Zhinong Gao, 1996 .

MUC1* Ligand, NM23-H1, Is a Novel Growth Factor That Maintains Human Stem Cells in a More Naïve State

K. Kosik, M. G. Carter, G. Lillacci, 2013, PloS one.

AN ALLOSAMIZOLINE/GLUCOSAMINE HYBRID NAGASE INHIBITOR

S. Withers, D. Vocadlo, S. Knapp, 1997 .

4-aminophenylalanine and 4-aminocyclohexylalanine derivatives as potent, selective, and orally bioavailable inhibitors of dipeptidyl peptidase IV.

Joseph L Duffy, G. Scapin, N. Thornberry, 2007, Bioorganic & medicinal chemistry letters.